AME

Business profile & competitive position

AMETEK, Inc. operates in the Industrials sector, specifically the Electrical Equipment & Parts industry. In everyday terms, it designs and manufactures electronic instruments and electromechanical devices through two operating groups. Electronic Instruments (EIG) produces advanced analytical, test and measurement equipment for process, aerospace, power and industrial markets. Electromechanical (EMG) supplies precision motion control, thermal management, specialty metals, electrical interconnects and highly engineered medical components and devices, with major end markets including aerospace, defense, medical and industrial automation.

The financial profile supports the idea of a niche, high-specification manufacturer rather than a commodity parts supplier. In 2025, AMETEK generated sales of $7,401.1 million, up 6.6% from 2024, and delivered diluted earnings per share of $6.40, up 7.9%. The company also reported record operating income, net income, orders and backlog. On a trailing basis the net margin is 20.0% and return on equity is 14.5%, both relatively strong for an industrial components business. A 20.0% net margin implies considerable pricing power, engineering differentiation and long-cycle customer relationships because off-the-shelf electrical-component businesses rarely sustain that level of profitability. The 14.5% ROE, combined with the company’s buy-and-build strategy, suggests capital is being deployed into businesses that generate above-cost returns.

The competitive moat is therefore best understood as a portfolio of specialized product lines with high switching costs, regulatory certifications and deep engineering content, reinforced by continuous operational improvement. From 2021 through December 31, 2025, AMETEK completed 15 acquisitions representing roughly $1.8 billion in annualized sales, which has expanded its technology footprint and end-market reach.

Financial posture

As of the current snapshot, AMETEK carries a market capitalization of $57.8 billion and trades at a P/E of 36.7, with the stock at $252.375. For context, the 50-day exponential moving average sits at $243.93 and the RSI is 59.5, neither deeply overbought nor oversold. A P/E of 36.7 is a notable premium to many broad industrial names and reflects the market’s willingness to pay for a consistently profitable, low-beta compounder; beta here is 0.96, meaning the stock historically moves roughly in line with the overall market, not dramatically more volatile.

The 20.0% net margin and 14.5% ROE reinforce the valuation narrative: AMETEK is priced as a high-quality operator. What the headline valuation does not reveal is leverage, because a debt figure is not included in this snapshot. However, the company’s 2025 cash outlay of $933.2 million, net of cash acquired, for the Kern and FARO Technologies acquisitions shows that AMETEK is actively redeploying capital to extend its technology and precision-manufacturing platform. The combination of steady organic execution and disciplined M&A is the financial signature management wants investors to associate with the name.

Strategic priorities & outlook

AMETEK’s most recent 10-K describes a clear, repeatable playbook. The company’s stated Growth Model targets high-single-digit annual sales growth, double-digit annual EPS growth, strong free cash flow generation and a superior return on total capital. Those goals are pursued through Operational Excellence initiatives that include lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens and the use of digitalization and artificial intelligence.

Acquisition activity remains central. From 2021 through the end of 2025, AMETEK completed 15 acquisitions with combined annualized sales of approximately $1.8 billion. The 2025 additions of Kern, a precision-machining and optical-inspection solutions provider, and FARO Technologies, a 3D measurement and imaging solutions business, cost $933.2 million in cash, net of cash acquired. Geographic expansion is likewise explicit: AMETEK maintains best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia to be close to customers and support international growth. In 2025, 52% of EIG’s net sales and 42% of EMG’s net sales were to customers outside the United States, and the company employed approximately 22,500 people as of year-end.

Macro & geopolitical exposure

The Electrical Equipment & Parts industry sits in the middle of multiple industrial value chains, so the business is exposed to industrial capital spending, aerospace and defense budgets, medical equipment demand, and factory automation cycles. Because AMETEK’s products involve precision electronics, specialty metals and electromechanical content, the sector is also sensitive to semiconductor and integrated-circuit availability, copper and rare-earth pricing, logistics costs and the overall health of global manufacturing.

Currency is a concrete factor here: more than half of EIG sales and about two-fifths of EMG sales are to non-U.S. customers. A stronger U.S. dollar would mechanically reduce the translated value of overseas revenue, while a weaker dollar would flatter it. Trade policy matters as well; AMETEK sources and manufactures in China, Mexico, the European Union and other regions, so tariffs, export controls or sanctions affecting precision components could alter cost structures or customer access. Aerospace and defense exposure adds budget-policy risk, and medical-device content adds regulatory exposure, including FDA and equivalent international bodies. None of these are unique to AMETEK, but they are the macro and geopolitical channels through which an Electrical Equipment & Parts business is most likely to be affected.

Recent developments

The most recent news flow has been generally positive. On October 9, 2026, defenseworld.net reported that GAMMA Investing LLC had bought shares of AMETEK stock. On October 8, 2026, Zacks published an article asking why Ametek could beat earnings estimates again. On October 5, 2026, Zacks noted that Ametek was up 0.47% in one week, and on October 1, 2026, Zacks covered an upgrade of Ametek’s rating to Buy. These headlines reflect incremental institutional interest and improving sell-side sentiment, though they should be read as snapshots of analyst and investor mood rather than as a signal to act.

AMETEK is scheduled to report earnings next on October 29, 2026, before the market opens, with a consensus EPS estimate of $2.11. That compares against the prior reported quarter’s actual EPS of $2.09.

Earnings behavior & post-earnings drift

AMETEK’s earnings history shows an unusually consistent beat record. Over the last eight reported quarters, the company has beaten the official estimate every time, for a 100% beat rate, while averaging a 4% earnings surprise. The last four quarters, listed from most recent to oldest, are illustrative: on August 4, 2026, AMETEK reported $2.09 versus the $1.99 estimate, a 5.0% beat, with the stock up 0.28% the next day and up 0.89% over the following five trading days. On April 30, 2026, EPS came in at $1.97 against a $1.90 estimate, a 3.7% beat, yet the stock fell 2.13% the next day and 0.33% over the next five days. The February 3, 2026 quarter produced $2.01 versus $1.94, a 3.6% beat, with the stock down 0.48% the next day but up 1.83% over the next five sessions. Finally, on October 30, 2025, AMETEK delivered $1.89 versus $1.76, a 7.4% beat, sending the stock up 1.91% the next day before it drifted down 0.54% over the following five days.

Across those same eight quarters, the average five-day post-earnings price move is just 0.46%, classified as “flat.” This pattern is important for educational purposes: even with a perfect beat rate and 4% average surprise, the stock does not reliably rocket after results. One explanation is that the market’s real expectation, or the unofficial consensus, already embeds a beat and the focus quickly shifts to forward guidance, margin trajectory and order commentary. Another possibility is the mechanical effect of elevated pre-event expectations and post-earnings volatility compression. For the upcoming October 29 report, the official consensus is $2.11, up modestly from the $2.09 printed last quarter.

For a deeper dive into how the sell side is positioning around the next report and what the full institutional verdict looks like, consult the consolidated analyst view and rating history rather than relying on any single headline.